vs
Astrana Health, Inc.（ASTH）与Castellum, Inc.（CTM）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是Castellum, Inc.的75.7倍（$950.5M vs $12.6M）。Astrana Health, Inc.净利率更高（0.7% vs -10.5%，领先11.2%）。Astrana Health, Inc.同比增速更快（42.9% vs 21.9%）。过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 5.3%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
Castellum, Inc.是一家总部位于美国的网络安全与信息技术服务提供商，服务覆盖国防政府机构、公共部门及商业企业客户，提供威胁检测、数据保护、云安全及托管IT解决方案，助力客户防范网络风险、保护核心数字资产。
ASTH vs CTM — 直观对比
营收规模更大
ASTH
是对方的75.7倍
$12.6M
营收增速更快
ASTH
高出21.0%
21.9%
净利率更高
ASTH
高出11.2%
-10.5%
两年增速更快
ASTH
近两年复合增速
5.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $12.6M |
| 净利润 | $6.6M | $-1.3M |
| 毛利率 | — | 33.9% |
| 营业利润率 | 1.9% | -11.1% |
| 净利率 | 0.7% | -10.5% |
| 营收同比 | 42.9% | 21.9% |
| 净利润同比 | 184.4% | 51.8% |
| 每股收益（稀释后） | $0.12 | $-0.02 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCTM
| Q4 25 | $950.5M | $12.6M | ||
| Q3 25 | $956.0M | $14.6M | ||
| Q2 25 | $654.8M | $14.0M | ||
| Q1 25 | $620.4M | $11.7M | ||
| Q4 24 | $665.2M | $10.3M | ||
| Q3 24 | $478.7M | $11.6M | ||
| Q2 24 | $486.3M | $11.5M | ||
| Q1 24 | $404.4M | $11.3M |
净利润ASTHCTM
| Q4 25 | $6.6M | $-1.3M | ||
| Q3 25 | $373.0K | $415.4K | ||
| Q2 25 | $9.4M | $-322.1K | ||
| Q1 25 | $6.7M | $-1.2M | ||
| Q4 24 | $-7.8M | $-2.7M | ||
| Q3 24 | $16.1M | $-1.3M | ||
| Q2 24 | $19.2M | $-1.8M | ||
| Q1 24 | $14.8M | $-4.1M |
毛利率ASTHCTM
| Q4 25 | — | 33.9% | ||
| Q3 25 | — | 37.6% | ||
| Q2 25 | — | 36.1% | ||
| Q1 25 | — | 39.0% | ||
| Q4 24 | — | 40.0% | ||
| Q3 24 | — | 42.7% | ||
| Q2 24 | — | 40.6% | ||
| Q1 24 | — | 39.8% |
营业利润率ASTHCTM
| Q4 25 | 1.9% | -11.1% | ||
| Q3 25 | 2.0% | 3.0% | ||
| Q2 25 | 3.1% | -2.7% | ||
| Q1 25 | 3.3% | -12.7% | ||
| Q4 24 | 0.1% | -15.7% | ||
| Q3 24 | 5.9% | -11.9% | ||
| Q2 24 | 6.2% | -13.6% | ||
| Q1 24 | 7.5% | -23.6% |
净利率ASTHCTM
| Q4 25 | 0.7% | -10.5% | ||
| Q3 25 | 0.0% | 2.8% | ||
| Q2 25 | 1.4% | -2.3% | ||
| Q1 25 | 1.1% | -10.0% | ||
| Q4 24 | -1.2% | -26.6% | ||
| Q3 24 | 3.4% | -11.0% | ||
| Q2 24 | 3.9% | -16.0% | ||
| Q1 24 | 3.7% | -36.3% |
每股收益（稀释后）ASTHCTM
| Q4 25 | $0.12 | $-0.02 | ||
| Q3 25 | $0.01 | $0.00 | ||
| Q2 25 | $0.19 | $0.00 | ||
| Q1 25 | $0.14 | $-0.01 | ||
| Q4 24 | $-0.14 | $-0.05 | ||
| Q3 24 | $0.33 | $-0.02 | ||
| Q2 24 | $0.40 | $-0.03 | ||
| Q1 24 | $0.31 | $-0.08 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $779.3M | $35.8M |
| 总资产 | $2.2B | $41.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHCTM
| Q4 25 | $429.5M | — | ||
| Q3 25 | $463.4M | — | ||
| Q2 25 | $342.1M | — | ||
| Q1 25 | $260.9M | — | ||
| Q4 24 | $290.8M | — | ||
| Q3 24 | $350.3M | — | ||
| Q2 24 | $327.7M | — | ||
| Q1 24 | $337.3M | — |
总债务ASTHCTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $8.0M | ||
| Q3 24 | — | $8.3M | ||
| Q2 24 | — | $8.7M | ||
| Q1 24 | — | $9.0M |
股东权益ASTHCTM
| Q4 25 | $779.3M | $35.8M | ||
| Q3 25 | $775.5M | $36.7M | ||
| Q2 25 | $765.5M | $31.8M | ||
| Q1 25 | $745.4M | $26.1M | ||
| Q4 24 | $712.7M | $20.2M | ||
| Q3 24 | $704.6M | $12.0M | ||
| Q2 24 | $678.9M | $12.1M | ||
| Q1 24 | $653.5M | $12.8M |
总资产ASTHCTM
| Q4 25 | $2.2B | $41.9M | ||
| Q3 25 | $2.2B | $46.3M | ||
| Q2 25 | $1.4B | $43.4M | ||
| Q1 25 | $1.3B | $41.1M | ||
| Q4 24 | $1.4B | $37.8M | ||
| Q3 24 | $1.3B | $28.8M | ||
| Q2 24 | $1.3B | $29.5M | ||
| Q1 24 | $1.2B | $30.5M |
负债/权益比ASTHCTM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.40× | ||
| Q3 24 | — | 0.69× | ||
| Q2 24 | — | 0.72× | ||
| Q1 24 | — | 0.70× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $-661.7K |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHCTM
| Q4 25 | $-2.9M | $-661.7K | ||
| Q3 25 | $10.0M | $1.0M | ||
| Q2 25 | $90.9M | $214.2K | ||
| Q1 25 | $16.6M | $-2.5M | ||
| Q4 24 | $-10.9M | $-394.4K | ||
| Q3 24 | $34.0M | $742.2K | ||
| Q2 24 | $23.2M | $748.6K | ||
| Q1 24 | $6.0M | $23.7K |
自由现金流ASTHCTM
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $7.4M | $957.0K | ||
| Q2 25 | $89.5M | — | ||
| Q1 25 | $13.6M | — | ||
| Q4 24 | $-13.5M | — | ||
| Q3 24 | $31.7M | $738.9K | ||
| Q2 24 | $20.4M | — | ||
| Q1 24 | $5.6M | — |
自由现金流率ASTHCTM
| Q4 25 | -0.6% | — | ||
| Q3 25 | 0.8% | 6.5% | ||
| Q2 25 | 13.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | -2.0% | — | ||
| Q3 24 | 6.6% | 6.4% | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | 1.4% | — |
资本支出强度ASTHCTM
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.3% | 0.3% | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.4% | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 0.6% | 0.0% | ||
| Q1 24 | 0.1% | 0.0% |
现金转化率ASTHCTM
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | 2.41× | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CTM
暂无分部数据
